Clinical Trial Update: Inhaled Corticosteroid Treatment of COVID19 Patients With Pneumonia [Phase 4]

View source ↗

Summary

Phase 4 trial update on inhaled corticosteroids for COVID-19 patients with pneumonia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronavirus Infection

Snippet

Sponsor: Sara Varea | Conditions: Coronavirus Infection | Phase 4 | Status: COMPLETED